Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (191-200 of 469) with videos related to

Pageof 47
Sort By:
Nuclear Medicine Communications|August 16, 2020
Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resectionShantanu S Pande, Nilendu Purandare, Ameya Puranik, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 8, 2016
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)Andrew J Stewart Coats, Gwo Fuang Ho, Kumar Prabhash, et al.
South Asian Journal of Cancer|January 2, 2023
Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective ReviewSatvik Khaddar, Akhil Kapoor, Vanita Noronha, et al.
JCO Global Oncology|February 7, 2025
Spotlight on Lung Cancer Disparities in IndiaManas Gunani, Rahul Winayak, Anisha Agarwal, et al.
Auris, Nasus, Larynx|December 31, 2018
Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the HistopathologyKhuzema Saifuddin Fatehi, Shivakumar Thiagarajan, Harsh Dhar, et al.
Lung Cancer (Auckland, N.Z.)|January 31, 2018
Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancerVidya H Veldore, Anuradha Choughule, Tejaswi Routhu, et al.
BMJ Open|March 17, 2021
Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1-5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trialAnil Tibdewal, Jai Prakash Agarwal, Shashank Srinivasan, et al.
South Asian Journal of Cancer|February 9, 2023
Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 InhibitorsAkhil Kapoor, Vanita Noronha, Vijay M Patil, et al.
Oral Oncology|December 27, 2025
Prevalence, risk Factors, and quality of life in patients with head and neck lymphedema following treatment for head and neck Cancer: The HeNLy-1 studyShivakumar Thiagarajan, T Rukmangathan, Drub Sharma, et al.
Journal of the Egyptian National Cancer Institute|May 22, 2021
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositisVanita Noronha, Vijay M Patil, Gunjesh Kumar Singh, et al.
Pageof 47

Showing results (191-200 of 469) with videos related to

Sort By:
Pageof 47
Nuclear Medicine Communications|August 16, 2020
Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resectionShantanu S Pande, Nilendu Purandare, Ameya Puranik, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 8, 2016
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)Andrew J Stewart Coats, Gwo Fuang Ho, Kumar Prabhash, et al.
South Asian Journal of Cancer|January 2, 2023
Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective ReviewSatvik Khaddar, Akhil Kapoor, Vanita Noronha, et al.
JCO Global Oncology|February 7, 2025
Spotlight on Lung Cancer Disparities in IndiaManas Gunani, Rahul Winayak, Anisha Agarwal, et al.
Auris, Nasus, Larynx|December 31, 2018
Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the HistopathologyKhuzema Saifuddin Fatehi, Shivakumar Thiagarajan, Harsh Dhar, et al.
Lung Cancer (Auckland, N.Z.)|January 31, 2018
Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancerVidya H Veldore, Anuradha Choughule, Tejaswi Routhu, et al.
BMJ Open|March 17, 2021
Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1-5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trialAnil Tibdewal, Jai Prakash Agarwal, Shashank Srinivasan, et al.
South Asian Journal of Cancer|February 9, 2023
Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 InhibitorsAkhil Kapoor, Vanita Noronha, Vijay M Patil, et al.
Oral Oncology|December 27, 2025
Prevalence, risk Factors, and quality of life in patients with head and neck lymphedema following treatment for head and neck Cancer: The HeNLy-1 studyShivakumar Thiagarajan, T Rukmangathan, Drub Sharma, et al.
Journal of the Egyptian National Cancer Institute|May 22, 2021
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositisVanita Noronha, Vijay M Patil, Gunjesh Kumar Singh, et al.
Pageof 47